Press release Les mer om Norway Royal Salmon ASA (NRS): Meldepliktig handel for nærstående av primærinnsider
Press release Les mer om Lytix Biopharma AS Announces FDA Acceptance of Verrica Pharmaceuticals' IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma